TeleSpecialists’ Position Statement on the Use of Tenecteplase
TeleSpecialists endorses the use of Tenecteplase for facilities in which Tenecteplase is listed in a formal policy statement as the frontline agent of choice for treatment of acute ischemic stroke when alteplase is not immediately and regularly available as an alternative.
TeleSpecialists will continue to monitor the evidence base for use of Tenecteplase.
Dr. Nima Mowzoon
CEO and Founder of TeleSpecialists, LLC
9/23/21